Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Allergy Clin Immunol. 2019 Jun 7;144(3):846–853.e11. doi: 10.1016/j.jaci.2019.05.030

Appendix Table 4. Relevant candidate patient subgroups, effect modifiers, for targeting the initiative and their data elements.

Relevant subgroup Data Elements
 (1) Primary language* Primary language is English, Spanish
 (2) Primary care vs specialty practices Internal medicine or family medicine versus allergy-immunology or pulmonary
 (3) Age 18-39 years, 40-49 years, ≥ 50 years
 (4) Skills that would support use of portal and asthma self-management Numeracy
Literacy-reading comprehension
Education
Computer literacy (Electronic Health Literacy Scale
Inhaler technique
 (5) Social Community barriers Food or clothing inadequacy
MOS Social Support§
Exposure to Violence
 (6) Trust of patient portal Patient portal preserves privacy
 (7) Depression and chronic disease load Depression**
Diabetes
Hypertension
High cholesterol
Obesity
Cancer
Current Smoker
 (8) Asthma severity Hospitalizations
ED visits
Intubation
Years taking ICS
Prednisone (Days/week)
 (9) Home environment Crowding at home (number of rooms, number of people at home)
Been without housing in last 6 months
Utilities shut off in the last 6 months
Times moved in last 12 months
Exposure to second hand smoke
*

Primary language was self-reported: English, Spanish.

Three literacy measures were used: Asthma Numeracy Questionnaire for numeracy,13 the Short Test of Functional Health Literacy in Adults12 for reading comprehension, and an item from the Electronic Health Literacy Scale: “I feel confident in using information from the internet to make health decisions.”14

Inhaler technique consisted of items from the Expert Panel Report24 and manufacturers’ instructions that were common to the type of inhaler, metered dose or dry powder inhaler. Inhaler technique was measured using a 7-point scale for a metered dose inhaler and a 6-point scale for a dry powder inhaler, testing the patient using the inhaler used for the patient’s inhaled steroid.

§

Social Support was measured with MOS Social Support Study.25

Exposure to violence was measured with a question adapted from Wright et al.8,26

Privacy concerns with the patient portal assessed using the Portal Use Baseline Survey (“I am concerned about looking up my personal health information on the internet” with a Likert 5-point response.)

**

Depression as measured by the Center for Epidemiologic Studies Depression Scale, a validated 20-item scale.15